Regulatory profile of phenformin with its adverse event in usa and rest of the world
International Journal of Development Research
Regulatory profile of phenformin with its adverse event in usa and rest of the world
Received 14th February, 2023; Received in revised form 03rd March, 2023; Accepted 17th March, 2023; Published online 27th April, 2023
Pharmaceutical market is vast growing market as per people need invention, modification and innovation is done in field of pharmaceuticals. As the market grow the safety and efficacy of drug is very important as drugs are consumed by a large number of populations. There has been mega outbreak before in the past time, so avoid that type of outbreak the post marketing studies is very important and should maintain pharmacovigilance data. The regulatory authorities of country should hold the responsibilities for the proper surveillance over the period of time up to particular drug is in market. Regulatory authorities should notify people of country about the ADR or the recalled drug. Just like drug phenformin was in the United States Market for long 20 years in spite of having fatal adverse drug reaction of Ketonuria and lactic acidosis. People should know the importance of aftermarket surveillance, ADR reporting, pharmacovigilance and should be aware about the drug use in day-to-day life.